Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Kalbe Farma (KLBF IJ)
Watchlist
139
Analysis
Health Care
•
Indonesia
PT Kalbe Farma Tbk produces and develops pharmaceutical products for human and animal healthcare. Through its subsidiaries, the Company also operates in the pharmaceutical, health food, and packaging industries.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Kalbe Farma
•
28 Feb 2024 20:03
•
Broker
Kalbe Farma - Retaining Our Conservative FY24 View
Post FY23 earnings (broadly in-line vs our est.), KLBF guides for further improvements in FY24F revenues/ EPS growth at 6-7% and 13-15% yoy.
BRI Danareksa Research
Follow
200 Views
Share
bullish
•
Kalbe Farma
•
28 Dec 2023 16:28
Kalbe Farma (KLBF IJ) - The End of a Long Transition
Kalbe Farma stands out with strong exposure to prescription drugs, consumer health and nutritional products providing for increasingly health...
Angus Mackintosh
Follow
628 Views
Share
bearish
•
Kalbe Farma
•
16 Nov 2023 20:41
•
Broker
Kalbe Farma (KLBF IJ) - Persisting Headwind in FY24 from Shifting Industry Trend
Against this headwind, we project a lower FY24F earnings growth of 2.9% yoy (21-27% cut in FY23-25F est.) and cut our rating to HOLD with a lower...
BRI Danareksa Research
Follow
357 Views
Share
bullish
•
Kalbe Farma
•
09 Oct 2023 11:34
•
Broker
Kalbe Farma (KLBF IJ) - Better Outlook Amid Potential 4Q23 Improved Margin
KLBF foresees better margins in 4Q23 and 2024, supported by the nutritional division (4Q23) and a favorable product mix (2024).
BRI Danareksa Research
Follow
243 Views
Share
bullish
•
Kalbe Farma
•
30 Sep 2021 23:50
Kalbe Farma (KLBF IJ)- Back to the Business of Health
Kable Farma remains a core healthcare proxy for Indonesia, coverings everything from prescription pharmaceuticals, consumer health, and...
Angus Mackintosh
Follow
359 Views
Share
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.30.3
x